NCT02476968
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02476968 |
| Title | To Assess the Efficacy and Safety of Olaparib Maintenance Monotherapy in the Treatment of Ovarian Cancer (ORZORA) |
| Acronym | ORZORA |
| Recruitment | Completed |
| Gender | female |
| Phase | FDA approved |
| Variant Requirements | Yes |
| Sponsors | AstraZeneca |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | POL | ITA | HUN | GBR | ESP | CZE | CAN | BGR |
CKB BOOST